Achieve Life Sciences (ACHV) Cash from Investing Activities Growth (1y) (2011 - 2026)
Achieve Life Sciences (ACHV) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Achieve Life Sciences |
93.71 Mn |
63.22 Mn |
- |
25.75% |
| Date | Value |
|---|
| Mar 31, 2026 |
25.75% |
| Dec 31, 2025 |
-93.95% |
| Sep 30, 2025 |
-195.35% |
| Dec 31, 2024 |
195,383.33% |
| Jun 30, 2020 |
-100.51% |
| Mar 31, 2020 |
-100.07% |
| Dec 31, 2019 |
99.97% |
| Jun 30, 2019 |
6,619.44% |
| Mar 31, 2019 |
26,800.00% |
| Dec 31, 2018 |
-1,463.60% |
| Sep 30, 2018 |
-164.74% |
| Jun 30, 2018 |
-104.74% |
| Mar 31, 2018 |
-99.89% |
| Dec 31, 2017 |
-97.39% |
| Sep 30, 2017 |
-74.69% |
| Jun 30, 2017 |
138.42% |
| Mar 31, 2017 |
250.06% |
| Dec 31, 2016 |
303.49% |
| Sep 30, 2016 |
175.02% |
| Jun 30, 2016 |
-169.45% |
